Vrbpac Meeting 2025

Vrbpac Meeting 2025. Schedule at a Glance AANS Annual Meeting 2025 abruptly cancel the planned meeting of the Vaccines and Related Biological Products Advisory Committee (VRBPAC), which is the annual opportunity for FDA to hear expert advice and make recommendations on the selection of strains to be included in the influenza virus vaccines for the 2025 to 2026 influenza season. The FDA's VRBPAC meeting scheduled for March 13, 2025, to select flu strains for the 2025-2026 season has been canceled, which may delay flu vaccine production

Schedule at a Glance AANS Annual Meeting 2025
Schedule at a Glance AANS Annual Meeting 2025 from annualmeeting.aans.org

An FDA spokesperson said the agency would make its recommendations to manufacturers public in time for updated vaccines to be available for the 2025-26 influenza season After canceling meeting of independent advisers, FDA issues 2025-26 flu vaccine recommendations

Schedule at a Glance AANS Annual Meeting 2025

The FDA's Vaccines and Related Biological Products Advisory Committee had been scheduled to. It comes as RFK Jr., a vaccine skeptic who now leads the Department of Health and Human Services, makes moves that could affect vaccination uptake and policy. The FDA's Vaccines and Related Biological Products Advisory Committee had been scheduled to.

2025 Theme Announcement AANS Annual Meeting 2025. After canceling meeting of independent advisers, FDA issues 2025-26 flu vaccine recommendations The FDA's Vaccines and Related Biological Products Advisory Committee had been scheduled to.

【中国科学报】中国科学院召开2025年度工作会议中国科学院2025年度工作会. It comes as RFK Jr., a vaccine skeptic who now leads the Department of Health and Human Services, makes moves that could affect vaccination uptake and policy. The CDC reports 33 million flu illnesses, 430,000 hospitalizations, and 19,000 deaths as of February 2025, with Influenza A(H1N1) and A(H3N2) as the primary strains.